Sigilon Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2020 to Q2 2023

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Sigilon Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2020 to Q2 2023.
  • Sigilon Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2023 was 2.5M shares, a 92.3% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 2.5M -29.9M -92.3% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 32.5M +126K +0.39% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 2.5M -29.9M -92.3% Dec 31, 2022 10-Q 2023-08-07
Q3 2022 32.5M +253K +0.79% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 32.4M +535K +1.68% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 32.4M +897K +2.85% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 32.4M +895K +2.84% Dec 31, 2021 10-K 2023-03-14
Q3 2021 32.2M Sep 30, 2021 10-Q 2021-11-10
Q2 2021 31.9M Jun 30, 2021 10-Q 2021-08-10
Q1 2021 31.5M Mar 31, 2021 10-Q 2021-05-10
Q4 2020 31.5M Dec 31, 2020 10-K 2022-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.